Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 1625 of 46697 entries
View as:
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 609
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 13
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 34
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 10
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Alborz Medical University | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alborz Medical University.temp.org | 2025-07-14 |
| Alcediag | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alcediag.temp.org | 2025-07-14 |
| Alchemia Oncology | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alchemia Oncology.temp.org | 2025-07-14 |
| Alcis | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alcis.temp.org | 2025-07-14 |
| Alcobra Ltd. | - | 8 | 0.0% | 0 | 0 | 0.0% | - | Alcobra Ltd..temp.org | 2025-07-14 |
| Alcohol Research Group | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alcohol Research Group.temp.org | 2025-07-14 |
| Alcon LenSx, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alcon LenSx, Inc..temp.org | 2025-07-14 |
| Alcon Research | - | 609 | 0.0% | 0 | 0 | 0.0% | - | Alcon Research.temp.org | 2025-07-14 |
| Alcon, a Novartis Company | - | 13 | 0.0% | 0 | 0 | 0.0% | - | Alcon, a Novartis Company.temp.org | 2025-07-14 |
| Alcresta Therapeutics, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alcresta Therapeutics, Inc..temp.org | 2025-07-14 |
| Alcyone Therapeutics, Inc | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alcyone Therapeutics, Inc.temp.org | 2025-07-14 |
| Aldagen | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Aldagen.temp.org | 2025-07-14 |
| Alden Cancer Therapy II | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alden Cancer Therapy II.temp.org | 2025-07-14 |
| Aldena Therapeutics | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aldena Therapeutics.temp.org | 2025-07-14 |
| Alder Biopharmaceuticals, Inc. | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Alder Biopharmaceuticals, Inc..temp.org | 2025-07-14 |
| Alder Hey Children's NHS Foundation Trust | - | 15 | 0.0% | 0 | 0 | 0.0% | - | Alder Hey Children's NHS Foundation Trust.temp.org | 2025-07-14 |
| Aldeyra Therapeutics, Inc. | - | 34 | 0.0% | 0 | 0 | 0.0% | - | Aldeyra Therapeutics, Inc..temp.org | 2025-07-14 |
| Aldy Heriwardito | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aldy Heriwardito.temp.org | 2025-07-14 |
| Alebund Pharmaceuticals | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Alebund Pharmaceuticals.temp.org | 2025-07-14 |
| Alebund Pty Ltd | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Alebund Pty Ltd.temp.org | 2025-07-14 |
| Alector Inc. | - | 10 | 0.0% | 0 | 0 | 0.0% | - | Alector Inc..temp.org | 2025-07-14 |
| Alejandra García-Novoa | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandra García-Novoa.temp.org | 2025-07-14 |
| Alejandra Guillermina Miranda Diaz | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandra Guillermina Miranda Diaz.temp.org | 2025-07-14 |
| Alejandra Ramírez Carrasco | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandra Ramírez Carrasco.temp.org | 2025-07-14 |
| Alejandro Berenstein | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Alejandro Berenstein.temp.org | 2025-07-14 |